Position
Chief Strategy Officer
Company
Avalo Therapeutics
RockvilleTherapeuticsBiotechnologyHealth CareDescription
Avalo Therapeutics, Inc. appointed Jennifer Riley as Chief Strategy Officer, effective January 1, 2025. In this role, Ms Riley will oversee corporate strategy and commercial and product pipeline planning to drive growth and innovation across the organization.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months